1. Chronic administration of morphine, nicotine or phenobarbitone has previously been shown to inhibit rat liver tryptophan pyrrolase activity by increasing hepatic [NADPHI, whereas subsequent withdrawal enhances pyrrolase activity by a hormonal-type mechanism. 2. It is now shown that this enhancement is associated with an increase in the concentration of serum corticosterone. 3. Chronic administration of the above drugs enhances, whereas subsequent withdrawal inhibits, brain 5-hydroxytryptamine synthesis. Under both conditions, tryptophan availability to the brain is altered in the appropriate direction. 4. The chronic drug-induced enhancement of brain tryptophan metabolism is reversed by phenazine methosulphate, whereas the withdrawal-induced inhibition is prevented by nicotinamide. 5. The chronic morphine-induced changes in liver [NADPHI, pyrrolase activity, tryptophan availability to the brain and brain 5-hydroxytryptamine synthesis are all reversed by the opiate antagonist naloxone. 6. It is suggested that the opposite effects on brain tryptophan metabolism of chronic administration and subsequent withdrawal of the above drugs of dependence are mediated by the changes in liver tryptophan pyrrolase activity. 6. Similar conclusions based on similar findings have previously been made in relation to chronic administration and subsequent withdrawal of ethanol. These findings with all four drugs are briefly discussed in relation to previous work and the mechanism(s) of drug dependence.
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We have previously reported (Badawy & Evans, 1973a ) that chronic ethanol administration to rats inhibits the activity of liver tryptophan pyrrolase (tryptophan 2,3-dioxygenase, EC 1.13.11.11) by increasing hepatic [NAD(P)H], whereas subsequent withdrawal causes a hormonal-type enhancement of pyrrolase activity that has been shown (Badawy et al., 1980) to be associated with an increase in serum corticosterone concentration. Liver tryptophan pyrrolase is one of the peripheral factors that influence brain 5-hydroxytryptamine synthesis by altering the availability of circulating tryptophan to the brain, and we presented evidence (Badawy et al., , 1980 Punjani et al., 1979) strongly suggesting that the above opposite changes in pyrrolase activity mediate the correspondingly opposite effects of chronic administration and subsequent withdrawal of ethanol on brain 5-hydroxytryptamine synthesis. Chronic administration of three other drugs of dependence (morphine, nicotine and phenobarbitone) also inhibits liver pyrrolase activity by a mechanism not involving a defective apoenzyme synthesis nor a decreased cofactor (haem) availability, but associated with an increased liver [NADPHI (Badawy & Evans, 1973b , 1975a .
That NADPH is the cause of the above inhibition is suggested by the then observed reversal of the inhibition by addition in vitro of NAD(P)+ or by administration in vivo of the regenerator of these oxidized dinucleotides phenazine methosulphate. Moreover, the above inhibition of pyrrolase activity by morphine, nicotine or phenobarbitone was not caused by NADH, because of the failure of the NAD+ regenerators fructose and pyruvate to reverse it. These latter compounds are capable of reversing the pyrrolase inhibition by chronic administration of ethanol, glucose or nicotinamide, all of which increase liver [NAD(P)H] (Badawy & Evans, 1975a , 1976a . It was also shown (Badawy & Evans, 1973b , 1975a that withdrawal of morphine, nicotine or phenobarbitone enhances liver tryptophan pyrrolase activity by a hormonal-type mechanism similar to that exerted by ethanol withdrawal. It was therefore decided to find out if the opposite effects of chronic administration and subsequent withdrawal of morphine, nicotine and phenobarbitone on liver pyrrolase activity are also involved in any likely changes in brain 5-hydroxytryptamine synthesis. Such investigation, which is also of interest in relation to the possible involvement of 5-hydroxytryptamine in drug dependence, forms the subject of the present paper. All animals were housed three per cage and were maintained on cube diet 41 B (Oxoid, Basingstoke, Hants., U.K.) and water (purchased rats were so maintained for at least 1 week before the start of experiments). Rats used for the determination of liver tryptophan pyrrolase activity were killed by stunning and cervical dislocation between 13:00 and 15:00h, whereas those used for all other determinations were killed by decapitation between 1 1:00 and 12:00h.
Materials and methods
Drugs of dependence were freely administered in drinking water for 3 weeks. Nicotine hydrogen (+)-tartrate was given at a constant concentration of 3.08mg (1mg of the free base) per 100ml of drinking water. Morphine sulphate was given in increasing concentrations (48h apart) of 0.1, 0.15, 0.2, 0.3 and finally 0.4 mg/ml, and the animals were then maintained on the latter concentration till the end of the 3-week experimental period. Similarly, phenobarbitone sodium was given in increasing concentrations (48h apart) of 1, 1.5, 2, 2.5 and finally 3mg/ml, and the animals were then maintained on the latter concentration till the end of the experimental period.
Some chronic drug-treated rats and their respective controls received, 2h before death, an intraperitoneal injection of either phenazine methosulphate (10mg/kg body wt.) or an equal volume (2ml/kg body wt.) of 0.9% (w/v) NaCl. Additionally, some chronic morphine-treated rats and their controls received, at various times before death, an intraperitoneal injection of either naloxone hydrochloride (1 mg/kg body wt.) or an equal volume (2.5 ml/kg) of 0.9% NaCl.
Withdrawal of drugs of dependence was achieved by replacing the drug solution with drinking water. The effects of withdrawal of morphine, phenobarbitone and nicotine were studied at 1, 2 and 3 days respectively after withdrawal. Other rats received during these withdrawal periods a solution of nicotinamide in drinking water (5 g/litre) to find out if this agent is capable of reversing the withdrawal effects.
Chemical, enzymic and other determinations
Tryptophan pyrrolase activity was determined in fresh liver homogenates (Badawy & Evans, 1975c) either in the absence (holoenzyme activity) or in the presence (total enzyme activity) of added (2#M) haematin. The apoenzyme activity was obtained by difference. Concentrations of liver nicotinamideadenine dinucleotides (phosphates) were determined in pieces obtained by a locally manufactured freeze-clamp by the direct method of Slater et al. (1964) with the minor modifications described by- Punjani et al. (1979) .
Free (ultrafiltrable) serum, total (acid-soluble) serum liver and brain tryptophan and brain 5-hydroxytryptamine and 5-hydroxyindol-3-ylacetic acid concentrations were determined by standard procedures (for references, see Badawy et al., 1979 for each group of four (pyrrolase activities) or of six rats (all other determinations). The values in columns 2 and 3 are compared with those in column 1, whereas those in column 4 are compared with those in column 3. Significance of differences is indicated as follows: ***P <0.02; ****P <0.01; *****P<0.005; ******P <0.001. Table 1 , except that the rats were given nicotine in drinking water for 3 weeks as described in the Materials and methods section. The significance of differences is indicated as follows: ****P < 0.01; *****P < 0.005; ******P < 0.001. proteins (expressed as a percentage of free serum tryptophan) was not significantly altered by morphine or nicotine, and was only slightly altered (by 8%; P < 0.025) by phenobarbitone.
The results in Tables 1-3 also show that phenazine methosulphate did not exert any significant effects on the various aspects of tryptophan metabolism examined in control rats, but was capable of reversing all the changes produced by chronic administration of the three drugs of dependence. The effects of these drugs and of phenazine methosulphate on serum glucose and corticosterone concentrations were also studied (results not shown). It was found that serum glucose concentration was not significantly altered (P>0.10) by any of these treatments, whereas that of serum corticosterone was increased by phenobarbitone (by only 7%; P<0.01) and by phenazine methosulphate administration to control or chronic drug-treated rats (by 19-29%; P = 0.005-0.001).
Brain tryptophan concentration plays an important role in 5-hydroxytryptamine synthesis (Curzon & Knott, 1974 , and references cited therein; Badawy & Evans, 1976b; Badawy et al., 1979 Badawy et al., , 1980 , and the increases in brain tryptophan, 5-hydroxytryptamine and 5-hydroxyindol-3-ylacetic acid concentrations caused by chronic administration of morphine, nicotine and phenobarbitone are therefore consistent with these three drugs enhancing brain 5-hydroxytryptamine synthesis by increasing brain tryptophan concentration. That this latter increase is not insulin-mediated or lipolysis-dependent is suggested by the absence of changes in serum glucose concentration (see above) or in tryptophan binding to serum proteins (see Tables 1-3) . It is therefore likely that the chronic drug-induced increase in brain tryptophan concentration is caused by the increase in the availability of circulating tryptophan to the brain, because of the proportionate increases in free serum and total serum tryptophan concentrations. That this increased availability of tryptophan may be secondary to the inhibition of liver tryptophan pyrrolase activity leading to a decreased hepatic tryptophan catabolism is suggested by the observed increase in liver tryptophan concentration (Tables 1-3) . Similar results have been reported under conditions involving the inhibition of liver tryptophan pyrrolase activity by chronic administration of ethanol or nicotinamide (Badawy et al., 1980) . More direct evidence for the possible involvement of the inhibition of liver pyrrolase activity by chronic administration of drugs of dependence in the increased availability of circulating tryptophan to the brain is provided by the findings ( Tables 1-3) that reversal by phenazine methosulphate of the former effect also reverses the chronic drug-induced accumulation of tryptophan in the liver and the increased concentrations of the amino acid in serum and brain. Phenazine methosulphate (and the liver NAD+ regenerators fructose, Methylene Blue and pyruvate) have previously been shown to reverse the effects of chronic ethanol administration on liver pyrrolase activity and on tryptophan availability to the brain. It may therefore be suggested that chronic administration of the above four drugs of dependence enhances brain 5-hydroxytryptamine synthesis by increasing tryptophan availability to the brain secondarily to the inhibition of liver pyrrolase activity.
Reversal by naloxone of the effects of chronic morphine administration on liver and brain tryptophan metabolism Shen et al. (1970) reported that the opiate antagonist naloxone reverses the chronic morphineinduced enhancement of brain 5-hydroxytryptamine synthesis. In view of the present findings with morphine (Table 1) , it was considered important to find out if naloxone is also capable of reversing the morphine effects on tryptophan availability to the brain and possibly also on liver tryptophan pyrrolase activity. The results in Table 4 show that the chronic morphine-induced increases in free serum, total serum, liver and brain tryptophan and brain 5-hydroxytryptamine and 5-hydroxyindol-3-ylacetic acid concentrations (22, 26, 24, 31, 20 and 24% respectively) were all reversed at 2 h after administration of naloxone. This antagonist did not exert any significant effects on these parameters in control rats. These findings with naloxone therefore provide further evidence that the chronic morphine-induced enhancement of brain 5-hydroxytryptamine synthesis is caused by the increase in tryptophan availability to the brain. Messing et al. (1978) also reported that chronic morphine administration increases brain tryptophan concentration, but they also found that this increase was potentiated by naloxone. This latter effect contrasts with that observed in the present work, and one possible explanation of this may be the different conditions under which the authors performed their experiments.
In experiments not shown here, it was found that neither acute naloxone injection nor chronic morphine administration caused any significant changes in serum glucose or corticosterone concentration, but that only the latter was increased by 23% (P<0.01) when naloxone was administered to morphine-pretreated rats. Under these conditions, naloxone produced the so-called opiate-withdrawal syndrome (C. M. Evans & A. A.-B. Badawy, unpublished work), despite the fact that our rats received doses of morphine considerably smaller than those used by other workers.
The reversal by naloxone of the chronic effects of morphine on tryptophan availability to the brain described above suggests that this antagonist may also reverse the drug-induced inhibition of liver tryptophan pyrrolase activity. That this is so is shown in Table 5 . The chronic morphine-induced decreases in activities of the total enzyme (44-67%; P-0.01-0.001) and apoenzyme (71-91%; P< 0.001) were no longer observed after naloxone administration. Moreover, this reversal by naloxone was a rapid phenomenon, occurring as early as 15 min after antagonist administration. These results therefore provide additional support to the suggestion that the chronic effects of morphine on brain tryptophan metabolism are mediated by the inhibition of liver tryptophan pyrrolase activity. Table 4 . Reversal of naloxone of the chronic morphine-induced increases in concentrations of tryptophan, 5-hydroxytryptamine and S-hydroxyindol-3-ylacetic acid in rat serum, liver and/or brain Morphine was administered in drinking water for 3 weeks as described in the Materials and methods section. Both control and morphine-treated rats received, at 2 h before death, an intraperitoneal injection of either naloxone hydrochloride (1 mg/kg body wt.) or an equal volume (2.5 ml/kg body wt.) of 0.9% NaCl. Values are means + S.E.M. for each group of six rats, and all (except the percentage of free serum tryptophan) are expressed in ug/ml of serum or in ,g/g wet wt. of tissue. The values in columns 2 and 3 are compared with those in column 1, whereas those in column 4 are compared with those in column 3. The significance of differences is indicated as follows: *P <0.05; ****P < 0.0 1; *****P < 0.005; ******P < 0.00 1.
Tryptophan Table 6 show that the drug increased [NADPHI by 19% and also decreased [NAD+I by 14%, thus confirming the findings by the above authors in unfrozen livers of older rats, and that naloxone is capable of reversing these effects of morphine. These latter results and those in Table 5 Tables 7, 8 and 9 respectively. These effects were examined at 1, 3 and 2 days respectively after withdrawal of the above drugs in view of the previous findings (Badawy & Evans, 1975a,b) that these are the time intervals after withdrawal of the drugs at which maximum enhancement of liver tryptophan pyrrolase activity occurs. In support of these previous findings, the results in Tables 7-9 show that the activities of the pyrrolase holoenzyme, total enzyme and apoenzyme were enhanced during morphine withdrawal by 163, 150 and 139% respectively ( Table 7) . The corresponding increases observed during nicotine withdrawal (Table 8) were 160, 144 and 129% respectively, whereas those caused by phenobarbitone withdrawal (Table 9) were 150, 151, and 153% Table 7 . Effects of morphine withdrawal on rat liver and brain tryptophan metabolism and on serum corticosterone concentration and their prevention by nicotinamide Morphine was administered in drinking water for 3 weeks as described in the Materials and methods section. Experiments were performed at 1 day after withdrawal of morphine. Some rats withdrawn from morphine also received a solution of nicotinamide in drinking water (5 g/litre) for the 24 h period. Liver tryptophan pyrrolase activity is in umol of kynurenine formed/h per g wet wt., serum corticosterone concentration is in ug/litre and all other values (except the percentage of free serum tryptophan) are in ug/ml of serum or in ug/g wet wt. of tissue. Values are means + S.E.M. for each group of four (pyrrolase activities) or six rats (all other determinations). The effects of morphine withdrawal with or without nicotinamide administration are compared with results in control rats. The significance of difference is indicated as follows: ****P < 0.0 1; ******P < 0.001. Determination Serum corticosterone and tryptophan metabolism parameters Morphine withdrawal 5.00 + 0.27****** 10.50 + 0.22****** 5.50 + 0.17****** 4.10 + 0.14****** 107.50 + 2.90****** 1.17 + 0.02****** 23.92 + 0.37****** 4.89 + 0.09 1.66 + 0.03****** 0.51 +0.006****** 0.27 + 0.010****** Nicotinamide during morphine withdrawal 1.80+0.04
1.80 + 0.04****** 0.00 + 0.00****** 6.85 + 0.30****** 90.60 + 3.20****** 1.87 ± 0.04****** 35.58 + 0.57****** 5.25 + 0.08 2.50 + 0.05****** 0.67 + 0.009****** 0.42 + 0.019**** Table 8 . Effects of nicotine withdrawal on rat liver and brain tryptophan metabolism and on serum corticosterone concentration and their prevention by nicotinamide Experimental details and comparisons, expressions and mean values of results are as described in Table 7 , except that the rats were given nicotine in drinking water for 3 weeks as described in the Materials and methods section, the experiments were performed at 3 days after withdrawal and nicotinamide was administered for the 3-day withdrawal period. The significance of difference is indicated as follows: ***P <0.02; ****P<0.01; *****P <0.005; ******P < 0.001.
Determination
Serum corticosterone and tryptophan metabolism parameters Treatment ...
Holo-(tryptophan pyrrolase)
Total tryptophan pyrrolase Table 7 , except that the rats were given phenobarbitone in drinking water for 3 weeks as described in the Materials and methods section, the experiments were performed at 2 days after phenobarbitone withdrawal and nicotinamide was administered for the 2-day withdrawal period. The significance of difference is indicated as follows: ******P < 0. Badawy & Evans, 1975c) , and this is supported by the observed (Tables 7-9 ) increases in serum corticosterone concentration (of 63-85%) during withdrawal of the above three drugs. Similar findings have been reported during ethanol withdrawal (Badawy et al., 1980) . Plasma corticosterone concentration has also been shown to be increased during withdrawal of opiates (Kokka et al., 1973) and nicotine (Benwell & Balfour, 1979) . The concentrations of free serum, total serum, liver and brain tryptophan and those of brain 5-hydroxytryptamine and 5-hydroxyindol-3-ylacetic acid were decreased during withdrawal of morphine, nicotine and phenobarbitone. Morphine withdrawal (Table 7) decreased the above concentrations by 22, 18, 24, 20, 16 and 23% respectively. The corresponding decreases by nicotine withdrawal (Table 8) were 27, 20, 25, 18, 18 and 22% respectively, whereas those by phenobarbitone withdrawal (Table  9) were 20, 20, 22, 20, 15 and 20% respectively. Tryptophan binding to serum proteins (expressed as a percentage of free serum tryptophan) was not significantly altered by withdrawal of any of these three drugs.
In experiments not shown here, it was found that serum glucose concentration was not significantly altered by withdrawal of the above drugs.
These results therefore suggest that withdrawal of morphine, nicotine and phenobarbitone inhibits brain 5-hydroxytryptamine synthesis by decreasing tryptophan availability to the brain secondarily to the enhancement of liver tryptophan pyrrolase activity and the associated increase in hepatic tryptophan catabolism. Similar conclusions have been reached on the basis of similar findings from experiments in which pyrrolase activity was enhanced by ethanol withdrawal (Badawy et aL, 1980) or by acute administration of cortisol (Green et al., 1975) or ethanol (Badawy & Evans, 1976b) . More direct evidence for the involvement of the enhanced liver pyrrolase activity in the drug-withdrawal-induced inhibition of brain tryptophan metabolism is provided by the findings (Tables 7-9) that nicotinamide [a tryptophan pyrrolase inhibitor (Badawy & Evans, 1976a) ] administration during the withdrawal phases not only prevented the enhancement of liver pyrrolase activity and the decreases in concentrations of tryptophan and hydroxyindoles in liver, serum and/or brain, but also caused inhibition of the total pyrrolase and apoenzyme activities (of 57-100%) and increases in tryptophan and hydroxyindole concentrations (of 10-37%o), in comparison with values observed in control rats. The effects of nicotinamide on these parameters in these latter rats have previously been reported. It was then found (Badawy et al., 1980) that nicotinamide administration for 8 days inhibited the pyrrolase total enzyme and apoenzyme activities by 49 and 77% respectively, and increased the concentrations of free serum, total serum, liver and brain tryptophan and brain 5-hydroxytryptamine and 5-hydroxyindol-3-ylacetic acid by 26, 26, 26, 30, 22 and 29% respectively. All these effects of nicotinamide in control rats are not dissimilar to those observed when it was administered during drug withdrawal (Tables 7-9 ) and also during ethanol withdrawal (Badawy et al., 1980) . This suggests that the ability of nicotinamide to exert its effects in control rats is not impaired by the opposite effects of withdrawal of drugs of dependence.
The results in Tables 7-9 also show that nicotinamide prevented the increases in serum corticosterone concentration caused by withdrawal of nicotine or phenobarbitone, but that it was only partially effective in preventing that caused by morphine withdrawal. In experiments not shown here, it was found that neither drug withdrawal nor nicotinamide administration during withdrawal caused any significant changes in serum glucose concentration.
Previous studies of the effects of chronic administratiron and subsequent withdrawal of drugs of dependence on brain tryptophan metabolism Such studies with ethanol have previously been discussed (Badawy et al., , 1980 . Chronic phenobarbitone administration does not alter brain 5-hydroxytryptamine concentration, whereas subsequent withdrawal (at 3 days) causes a decrease (Bantutova et al., 1978) . This latter finding is similar to that of the present work (Table 9) . Chronic administration and subsequent withdrawal of nicotine have been reported (Benwell & Balfour, 1979) to decrease brain hippocampal 5-hydroxytryptamine concentration. This finding, however, cannot be compared directly with those in the present work (Tables 2 and 8 ) because of differences in drug administration procedures. By contrast, numerous reports on the effects of chronic morphine administration on brain 5-hydroxytryptamine synthesis and turnover have been published. Many of the findings are contradictory (for references, see Way, 1972; Way et al., 1974) , and this may be explained by differences in strains and/or species of animals used, routes of administration of, and duration of treatment with, morphine, and methods of assessment of rates of synthesis and turnover of 5-hydroxytryptamine. However, the view (Way, 1972) that morphine enhances these rates is supported by the present findings (Tables 1 and 4) . One additional possible explanation of the failure of some workers to demonstrate the above enhancement is that of choice of the experimental time interval after morphine administration. In a number of investigations (see, e.g., Bhargava & Matwyshyn, 1977; Bhargava, 1979) , tests were carried out many hours after the last of the daily morphine injection(s) or after removal of the implanted drug. The results in Table 7 in the present work showing that brain tryptophan metabolism is inhibited at 24 h after morphine withdrawal suggest that, at an earlier time interval, brain tryptophan metabolism might have returned from the stimulated state to the normal one.
Mechanism(s) ofdrug dependence
The biochemical pathology of drug dependence is more likely to be advanced by examining what such lesion-producing drugs exert in common, rather than by trying to differentiate between them. In addition to providing considerable support to the concept of the inverse relationship between liver tryptophan pyrrolase activity and brain 5-hydroxytryptamine synthesis, the present findings are the first to establish that four drugs of dependence of different chemical classes share, other than depression of the central nervous system and the production of physical dependence, the single property of influencing brain 5-hydroxytryptamine synthesis in similar fashions, by acting on liver tryptophan pyrrolase activity. Moreover, the ability of naloxone to reverse the chronic effects of morphine on liver tryptophan and dinucleotide metabolism illustrates a new and unique aspect of the actions of this opiate antagonist. In view of the possible involvement of 5-hydroxytryptamine in mood regulation and in depressive illness (Curzon, 1969; Lapin & Oxenkrug, 1969; van Praag, 1978 and references cited therein), it is not unreasonable to suggest that the actions of drugs of dependence on tryptophan metabolism reported here may be related to the mechanism(s) of drug dependence. It may therefore be of interest to find out if tryptophan metabolism is similarly disturbed in drug-dependent patients, and, if so, whether the withdrawal symptoms exhibited by such patients could be prevented by therapy with agents such as nicotinamide.
